Cheri Donnelly

Research Assistant

Cheri Donnelly is a Research Assistant at RA Capital Management. Cheri’s primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Prior to RA Capital, Cheri worked as a Molecular Immunology Co-op at BioNTech. Cheri also worked as an Assay Development Co-op and Contractor at Nanopath – an early-stage start up – supporting research and internal operations. Cheri holds a BS in Biochemistry from Northeastern University.